The aim of this study was to determine whether the clinical outcome of autologous chondrocyte transplantation was dependent on the timing of a high tibial osteotomy in tibio-femoral mal-aligned knees. Between 2000 and 2005, forty-eight patients underwent autologous chondrocyte implantation with HTO performed at varying times relative to the second stage autologous chondrocyte implantation procedure. 24 patients had HTO performed simultaneously with their second stage cartilage transplantation, (the HTO Simultaneous Group). 5 patients had HTO prior to their cartilage procedure, (the HTO pre-ACI Group) and 19 had HTO performed between 1 to 4 years after their second stage cartilage implantation, (the HTO post-ACI Group). There were 29 men and 19 women with a mean age of 37 years (Range 28 to 50) at the time of their second stage procedure. With average follow-up of 72 months we have demonstrated a significant functional benefit in performing the HTO either prior to or simultaneously with the ACI procedure in the mal-aligned knee. The failure rate in the Post-ACI group was 45% compared to the Pre-ACI and Simultaneous group, with failure rates of 20% and 25%, respectively. An HTO performed prior to or simultaneously with an autologous chondrocyte implantation procedure in the mal-aligned knee, provides a significant protective effect by reducing the failure rate by approximately 50%.
Following bone tumour resection, lower limb reconstruction results in leg-length discrepancy in skeletally immature patients. Previously, minimally invasive endoprostheses have been associated with a high risk of complications including joint stiffness, nerve injury, aseptic loosening and infection. The purpose of this study was to examine the outcome of the Stanmore non-invasive extendible endoprostheses used in our institution between 2002 and 2009 and compare them with implants used in the past. Fifty-five children with a mean age of 11.4 years (5 to 16) underwent limb reconstruction with thirty-three distal femoral, two total femoral, eight proximal femoral and twelve proximal tibial implants. Forty-six endoprostheses were lengthened in clinic without anaesthesia using the principle of electromagnetic induction. Patients were assessed using the Musculoskeletal Tumour Society Score (MSTS) and the Toronto Extremity Salvage Score (TESS).Introduction
Methods
Melorheostosis is a rare bone dysplasia characterized by its classic radiographic appearance resembling dripping candle wax. The condition was originally described by Leri and Joanny in 1922. Its etiology is not fully known and treatment in most instances has been symptomatic. There are nearly 350 reported cases on melorheostosis, joint replacement has been successfully attempted in the shoulder and knee joint. We describe a case of severe melorheostosis affecting the left hip causing secondary osteo-arthritis, which was treated with a total hip replacement (THR). To the best of our knowledge this is the first reported case of its kind in the World literature. A 52-year-old male of Indian origin with known melorheostosis of the left leg for over 30 years, presented with symptoms suggestive of severe osteo-arthritis of the left hip. Previously he had been treated for melorheostosis of the knee joint (fig 1a & 1b) with excisions and decompression of the medial femoral condyle. His left hip became more painful over the last few years. He had a fixed flexion deformity of 20° of the hip, severe muscle wasting and the affected leg was 3 cm longer than the right leg. Radiographs (fig 2a & 2b) confirmed the presence of sclerotic new bone in the acetabulum eroding the femoral head. He had the classical dripping candle wax appearance along the medial border of the neck and shaft of the femur. He underwent a THR using a Corail-Pinnacle un-cemented prosthesis using ceramic on polyethylene bearing surfaces (fig 3a & 3b). Post operatively he made a quick recovery and there was a marked improvement in his symptoms and functional outcome scores at 6 weeks.Introduction
Case history
